Patents by Inventor Anatoli Gleiberman

Anatoli Gleiberman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of toll-like receptor agonist for treating cancer
    Patent number: 11628201
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Grant
    Filed: July 21, 2020
    Date of Patent: April 18, 2023
    Assignee: Cleveland BioLabs, Inc.
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov
  • USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER
    Publication number: 20210169972
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Application
    Filed: July 21, 2020
    Publication date: June 10, 2021
    Inventors: Anatoli GLEIBERMAN, Lyudmila BURDELYA, Andrei GUDKOV
  • Use of toll-like receptor agonist for treating cancer
    Patent number: 10780152
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Grant
    Filed: February 19, 2019
    Date of Patent: September 22, 2020
    Assignee: Cleveland BioLabs, Inc.
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov
  • USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER
    Publication number: 20190275128
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Application
    Filed: February 19, 2019
    Publication date: September 12, 2019
    Inventors: Anatoli GLEIBERMAN, Lyudmila BURDELYA, Andrei GUDKOV
  • Use of toll-like receptor agonist for treating cancer
    Patent number: 10265390
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: April 23, 2019
    Assignee: CLEVELAND BIOLABS, INC.
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov
  • USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER
    Publication number: 20180344823
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Application
    Filed: June 21, 2018
    Publication date: December 6, 2018
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov
  • Use of toll-like receptor agonist for treating cancer
    Patent number: 10034926
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Grant
    Filed: June 23, 2017
    Date of Patent: July 31, 2018
    Assignee: Cleveland BioLabs, Inc.
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov
  • USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER
    Publication number: 20180028628
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Application
    Filed: June 23, 2017
    Publication date: February 1, 2018
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov
  • USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER
    Publication number: 20170065692
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Application
    Filed: August 19, 2016
    Publication date: March 9, 2017
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov
  • USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER
    Publication number: 20160206690
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Application
    Filed: November 23, 2015
    Publication date: July 21, 2016
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov
  • Use of Toll-Like Receptor agonist for treating cancer
    Patent number: 9376473
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Grant
    Filed: January 10, 2012
    Date of Patent: June 28, 2016
    Assignee: Cleveland BioLabs, Inc.
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov
  • USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER
    Publication number: 20140248260
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Application
    Filed: January 10, 2012
    Publication date: September 4, 2014
    Applicant: CLEVELAND BIOLABS, INC.
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov